NDC 42961-209

Xpect Naproxen Sodium

Naproxen Sodium

Xpect Naproxen Sodium is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Cintas Corporation. The primary component is Naproxen Sodium.

Product ID42961-209_39ee1ea9-b45b-4137-833d-213a21bc69ce
NDC42961-209
Product TypeHuman Otc Drug
Proprietary NameXpect Naproxen Sodium
Generic NameNaproxen Sodium
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-03-31
Marketing CategoryANDA /
Application NumberANDA091353
Labeler NameCintas Corporation
Substance NameNAPROXEN SODIUM
Active Ingredient Strength220 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 42961-209-02

25 PACKET in 1 BOX (42961-209-02) > 1 TABLET in 1 PACKET (42961-209-01)
Marketing Start Date2021-03-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 42961-209-01 [42961020901]

Xpect Naproxen Sodium TABLET
Marketing CategoryANDA
Application NumberANDA091353
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-05-17

NDC 42961-209-02 [42961020902]

Xpect Naproxen Sodium TABLET
Marketing CategoryANDA
Application NumberANDA091353
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-05-17

Drug Details

NDC Crossover Matching brand name "Xpect Naproxen Sodium" or generic name "Naproxen Sodium"

NDCBrand NameGeneric Name
0280-6000AleveNAPROXEN SODIUM
0280-6010AleveNAPROXEN SODIUM
0280-6020AleveNAPROXEN SODIUM
0280-0041Aleve Headache PainNaproxen Sodium
0113-7033basic care naproxen sodiumNaproxen Sodium
0113-7368Basic Care Naproxen SodiumNaproxen Sodium
0113-7901basic care naproxen sodiumNaproxen Sodium
0113-0901Good Sense Naproxen SodiumNaproxen Sodium
0113-1412good sense naproxen sodiumnaproxen sodium
0113-1773good sense naproxen sodiumNaproxen Sodium
0113-4368Good Sense Naproxen SodiumNaproxen Sodium
0280-0270MenstridolNAPROXEN SODIUM
0143-9908NAPROXENnaproxen sodium
0143-9916NAPROXENnaproxen sodium

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.